3B Pharmaceuticals from Berlin announced licensing agreement with Novartis Innovative Therapies
Berlin, April 24, 2023 – 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications, today announced that it has entered into an amended and restated…